## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.86 indicates fundamental undervaluation. Quality metrics strong (ROE 66%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-3.6% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($63.50)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. UBS Adjusts Price Target on Las Vegas Sands to $68 From $67, Maintains Neutral Rating**
- Source: marketscreener.com | 20251208T134727 | Neutral | Relevance: 99%
- UBS has increased its price target for Las Vegas Sands (LVS) to $68 from $67, while reiterating a Neutral rating on the stock. This adjustment reflects a modest change in UBS's valuation of the casino and resort operator.

**2. Amundi Acquires 342,562 Shares of Las Vegas Sands Corp. $LVS**
- Source: MarketBeat | 20251209T081133 | Somewhat-Bullish | Relevance: 99%
- Amundi increased its stake in Las Vegas Sands Corp. (LVS) by 32.4% during Q2 2025, purchasing 342,562 additional shares to own a total of 1,400,373 shares valued at approximately $67 million. This comes despite significant insider selling, with CEO Robert G. Goldstein selling 700,000 shares and total insider sales reaching $168 million over the last quarter. Las Vegas Sands reported better-than-expected earnings with $0.78 EPS and $3.33 billion in revenue, pays a $0.25 quarterly dividend, and holds a "Moderate Buy" consensus analyst rating.

**3. L2 Asset Management LLC Purchases 16,815 Shares of Las Vegas Sands Corp. $LVS**
- Source: MarketBeat | 20251208T122925 | Neutral | Relevance: 99%
-  L2 Asset Management LLC increased its stake in Las Vegas Sands Corp. (NYSE:LVS) by 42.8% during the second quarter, now owning 56,128 shares valued at approximately $2.44 million. This comes despite significant insider selling activity, with executives selling over 2.7 million shares totaling about $168 million in the last 90 days. Las Vegas Sands recently reported strong quarterly earnings, beating estimates with $0.78 EPS and $3.33 billion in revenue, and analysts maintain a "Moderate Buy" rating with an average target price of $65.60.

**4. Las Vegas Sands Stock: Is LVS Outperforming the Consumer Discretionary Sector?**
- Source: Barchart.com | 20251209T105425 | Bullish | Relevance: 99%
-  Las Vegas Sands (LVS) has significantly outperformed the broader Consumer Discretionary sector and competitor MGM Resorts International over various periods. The company's recent third-quarter 2025 results exceeded analyst expectations with strong revenue and adjusted EPS growth, driven particularly by its Marina Bay Sands property. Analysts maintain a "Moderate Buy" rating for LVS, with potential upside to its Street-high price target.

**5. The Bull Case For Las Vegas Sands (LVS) Could Change Following Executive Share Sales And Rising Short Interest - Learn Why**
- Source: Simply Wall Street | 20251209T162121 | Neutral | Relevance: 99%
-  Recent executive share sales and increased short interest in Las Vegas Sands (LVS) are raising investor concerns, despite the company's refocused strategy on Asian integrated resorts and positive Macau casino revenue data. These bearish signals are prompting a reevaluation of the investment narrative, even as the company projects significant revenue and earnings growth by 2028 based on its Asian market focus. The mixed signals highlight a tension between insider actions and fundamental drivers in the investment landscape.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($13.25M) |
| Sells | 12 ($64.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.6% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $65M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Forward P/E 21.1x stretched relative to 10% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (2 raises, avg +12%). Insider selling cluster ($64.9M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $46.0B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 21.1 |
| Current P/E | 23.1 |
| YoY Growth | 9.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 2.7% to -0.9% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.9pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.90% (CS: 50) | Neutral |
| RSI_14 | 61.4 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.129x | Above |
| vs SMA200 | 1.375x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $67.08
- **Stop Loss:** $63.50 (5.3% risk)
- **Target:** $74.24 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 139
- **Position Value:** $9,324.12
- **Portfolio %:** 9.32%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*